<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jianyi D</submitter><funding>National Science Foundation of China</funding><pagination>73-85</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9813028</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>72(1)</volume><pubmed_abstract>Immunosuppression induced by myeloid-derived suppressor cells (MDSCs) is one of the main obstacles to the efficacy of immunotherapy for cervical cancer. Recent studies on the immunosuppressive ability of MDSCs have primarily focused on T cells, but the effect of MDSCs on B cells function is still unclear. In a study of clinical specimens, we found that the accumulation of MDSCs in patients with cervical cancer was accompanied by high expression of B cell activating factor (BAFF) on the surface and high expression of interleukin (IL)-10-producing B cells (B10) in vivo. We found that the absence of BAFF could significantly inhibit tumor growth in a cervical cancer model using BAFF KO mice. Further studies showed that abundant MDSCs in cervical cancer induced B cells to differentiate into B10</pubmed_abstract><journal>Cancer immunology, immunotherapy : CII</journal><pubmed_title>Myeloid-derived suppressor cells cross-talk with B10 cells by BAFF/BAFF-R pathway to promote immunosuppression in cervical cancer.</pubmed_title><pmcid>PMC9813028</pmcid><funding_grant_id>81572546</funding_grant_id><funding_grant_id>81871167</funding_grant_id><funding_grant_id>81771529</funding_grant_id><pubmed_authors>Jianyi D</pubmed_authors><pubmed_authors>Qingliang Z</pubmed_authors><pubmed_authors>Haili G</pubmed_authors><pubmed_authors>Lingfei H</pubmed_authors><pubmed_authors>Baoyou H</pubmed_authors><pubmed_authors>Meiqin Y</pubmed_authors><pubmed_authors>Bo Y</pubmed_authors><pubmed_authors>Fang L</pubmed_authors><pubmed_authors>Haoran H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Myeloid-derived suppressor cells cross-talk with B10 cells by BAFF/BAFF-R pathway to promote immunosuppression in cervical cancer.</name><description>Immunosuppression induced by myeloid-derived suppressor cells (MDSCs) is one of the main obstacles to the efficacy of immunotherapy for cervical cancer. Recent studies on the immunosuppressive ability of MDSCs have primarily focused on T cells, but the effect of MDSCs on B cells function is still unclear. In a study of clinical specimens, we found that the accumulation of MDSCs in patients with cervical cancer was accompanied by high expression of B cell activating factor (BAFF) on the surface and high expression of interleukin (IL)-10-producing B cells (B10) in vivo. We found that the absence of BAFF could significantly inhibit tumor growth in a cervical cancer model using BAFF KO mice. Further studies showed that abundant MDSCs in cervical cancer induced B cells to differentiate into B10</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-04-04T11:35:35.895Z</modification><creation>2025-04-04T11:35:35.895Z</creation></dates><accession>S-EPMC9813028</accession><cross_references><pubmed>35725835</pubmed><doi>10.1007/s00262-022-03226-0</doi></cross_references></HashMap>